About Myriad
Events & Presentations
Corporate Governance
Myriad Milestones
2022 Investor Day Presentations
News
Financial
Corporate
Product
Pipeline
Financial Reporting
GAAP to Non-GAAP Reconciliation
Latest Earnings Release
Earnings Presentation
SEC Filings
Quarterly & Annual Reports
Investor FAQs
Email Alerts Subscription
Contact Us
About Myriad
Events & Presentations
Corporate Governance
Myriad Milestones
2022 Investor Day Presentations
News
Financial
Corporate
Product
Pipeline
Financial Reporting
GAAP to Non-GAAP Reconciliation
Latest Earnings Release
Earnings Presentation
SEC Filings
Quarterly & Annual Reports
Investor FAQs
Email Alerts Subscription
Contact Us
News Releases
Categories:
All Categories
Corporate
Products
Pipeline
Financial
Mar 02, 2023
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Products
Mar 01, 2023
Myriad Genetics Applauds New Expanded Carrier Screening Practice Guidelines from NSGC
Products
Feb 28, 2023
Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight® Volumes
Financial
Feb 22, 2023
Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023
Financial
Feb 09, 2023
Myriad Genetics to Participate in Upcoming Healthcare Conferences
Financial
Feb 07, 2023
Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing
Products
Jan 05, 2023
Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities
Products
Jan 04, 2023
Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference
Corporate
Dec 19, 2022
Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
Corporate
Dec 08, 2022
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model
Products
Nov 29, 2022
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Showcasing Advancements in Breast Cancer Risk Assessment and Treatment
Products
Nov 17, 2022
GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care
Products
Nov 14, 2022
Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
Products
Nov 10, 2022
Myriad Genetics Announces UroSuiteâ„¢, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
Products
Nov 03, 2022
New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
Products
Next page